The EnGeneIC Cancer Research Foundation is committed to supporting young Australian scientists through scholarships for post-graduate studies and fellowships. The Foundation was established following public interest in an Australian Story episode, aired in 2007 and again in 2011, that documented the founding of EnGeneIC by joint CEOs Dr. Jennifer MacDiarmid and Dr. Himanshu Brahmbhatt and their quest toward a cancer cure.
As a result of this story, The EnGeneIC Cancer Research Foundation was formed in 2011. The Foundation, while small, is committed to challenging existing approaches to treating cancer and to encouraging the development of therapies that are tailored to the individual and not simply standardised across patients. We do not believe that debilitating side effects of chemotherapy should simply be accepted as a necessary evil associated with treatment, and want to ensure that there are research programs, student and professionals who are constantly challenging the treatment norms to come up with novel and tailor-made medicine solutions, even in less common cancers that often receive little research funding.
We are committed to raising funds to continue our work in the following areas:
- Encouraging young Australian scientists through scholarships to complete PhD program or post-graduate studies in translational oncology research
- Supporting patients into early clinical trials with novel therapies
All funds raised are committed directly to the job at hand. The Foundation operates with no overhead expenses and all fundraising work is purely on a volunteer basis.